Cardiology · Mitral Stenosis

Long-Term Monitoring & Prognosis

At a Glance

Mitral stenosis needs lifelong follow-up even after balloon treatment or surgery. Echocardiograms track valve function and can detect the valve narrowing again or ongoing high pressure in the lungs; new symptoms should prompt a call to the cardiology team.

Mitral stenosis is a lifelong condition that requires consistent monitoring, even after a successful balloon procedure or surgery. Because the mechanical changes to the valve can continue or recur, “fixing” the valve is often the beginning of a new phase of care rather than the end of your journey ^[1]^[2].

The Surveillance Schedule

Regular imaging is the cornerstone of long-term management. While your specific schedule will be tailored by your cardiologist based on guidelines, your symptoms, and your rhythm, echocardiogram monitoring generally follows a framework based on severity ^[3].

Mild Disease: Often monitored every 3 to 5 years if you remain completely asymptomatic ^[3].
Moderate Disease: Typically checked every 1 to 2 years ^[3].
Severe Disease: Requires more frequent scans, usually every 6 to 12 months, or sooner if new symptoms appear ^[3]^[4].
Post-Intervention: After PMBC or surgery, you will receive a “baseline” echo to document the new valve function. Future follow-ups will be scheduled based on the type of intervention (e.g., watching a tissue valve for wear, or a repaired valve for restenosis) ^[5]^[6].

Understanding Restenosis

If you have had a balloon procedure (PMBC) for rheumatic disease, it is important to understand restenosis—the gradual re-narrowing of the valve. This is not a failure of the initial procedure, but rather a continuation of the underlying disease process ^[7].

In long-term cohorts of selected rheumatic patients treated with PMBC, about 25% experience restenosis over the following 6 to 10 years ^[1]^[7].
Event-free survival (meaning no need for a repeat procedure or surgery) is high early on, but declines over a 20-year span ^[2]^[8].
Risk factors for restenosis include a high initial Wilkins score, a heavily calcified valve, or a large left atrium ^[1]^[9]^[10].

Managing Persistent Pulmonary Hypertension

In some patients, the high blood pressure in the lungs (pulmonary hypertension) does not fully resolve even after the mitral valve is successfully opened ^[11]^[12]. This often happens if the high pressure was present for a long time, causing changes to the lung’s blood vessels ^[13]^[14].

Evaluation: Your echo estimates this pressure via the Right Ventricular Systolic Pressure (RVSP). If it remains high, it should prompt a careful evaluation for residual valve leakiness, left-ventricular stiffness, or other lung conditions. Sometimes a right-heart catheterization is needed to get precise measurements.
Treatment Caution: Treatment focuses heavily on managing your fluid volume and optimizing the left side of your heart. Pulmonary-hypertension-specific vasodilators are not routine for left-heart disease and can actually be harmful or worsen congestion. They should never be started without a thorough evaluation by a pulmonary hypertension specialist ^[12]^[15].

The Psychological Impact of “Watch and Wait”

Living with a chronic heart condition and waiting for the next scan can take an emotional toll. Many patients experience scan anxiety—a period of intense stress in the weeks leading up to an echocardiogram ^[16].
It is common to feel a sense of uncertainty, especially knowing that a second procedure may eventually be needed ^[16]. However, research shows that quality of life significantly improves after the mechanical obstruction is addressed ^[6]^[17]. Discussing these fears openly with your Heart Team and having a clear action plan for when to call the clinic between scans can help you feel more in control of your long-term health ^[18].

Common questions in this guide

How often do I need an echocardiogram for mitral stenosis?

The timing depends on the severity of the valve narrowing and your symptoms. People with asymptomatic mild disease are often checked every 3 to 5 years, moderate disease every 1 to 2 years, and severe disease every 6 to 12 months or sooner if symptoms change. After balloon treatment or surgery, a baseline echocardiogram helps guide future follow-up.

Can mitral stenosis return after balloon treatment?

Yes. Restenosis means the valve gradually narrows again after a percutaneous mitral balloon commissurotomy, particularly when the original disease was rheumatic. In long-term studies of selected rheumatic patients, about 25% developed restenosis over 6 to 10 years; this does not necessarily mean the first procedure failed.

What makes restenosis more likely after mitral valve treatment?

A high initial Wilkins score, a heavily calcified valve, and a large left atrium are associated with a greater risk of restenosis. Your cardiologist can compare these features with your follow-up echocardiograms to assess how the valve is changing over time.

Why can pulmonary hypertension continue after the mitral valve is opened?

If pressure in the lung circulation was high for a long time, the lung blood vessels may have changed and the pressure may not immediately return to normal. Persistent elevation can also relate to a residual valve leak, stiffness of the left side of the heart, or another lung condition, so additional evaluation is sometimes needed.

Are pulmonary hypertension medicines routinely used after mitral stenosis treatment?

Pulmonary-hypertension-specific vasodilators are not routinely used when high lung pressure is caused by left-heart disease. They may worsen fluid congestion in some patients, so they should not be started without a careful evaluation by a pulmonary hypertension specialist.

What symptoms should make me call my cardiology clinic before my next scan?

Contact your care team about new or worsening symptoms, a gradual decrease in exercise capacity, heart palpitations, or an irregular heartbeat. Having a clear plan for which changes require a call can make it easier to act between scheduled echocardiograms.

How can I manage anxiety before mitral stenosis echocardiograms?

Stress before a scheduled scan is common when you are living with a chronic heart condition. Discuss your concerns with your Heart Team, identify support people, and make a clear plan for when to contact the clinic so the waiting period feels more manageable.

Curated prompts to bring to your next appointment.

1.What is the recommended timing for my next echocardiogram based on my specific valve severity and recent procedure?
2.If my pulmonary artery pressure remains elevated, what specific tests should we do to determine the underlying cause?
3.For my post-PMBC or post-surgery monitoring, what specific measurements should we use as my new baseline for comparison?
4.How will we distinguish between normal age-related changes and 'restenosis' of the valve during my long-term follow-up?
5.What specific symptom changes should prompt me to call the clinic before my next scheduled scan?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Key takeaways

Mitral stenosis requires lifelong echocardiogram-based monitoring, even after balloon treatment or surgery.
Follow-up interval usually ranges from every 3 to 5 years for asymptomatic mild disease to every 6 to 12 months for severe disease, with moderate disease checked every 1 to 2 years.
After PMBC, restenosis, or gradual re-narrowing, can occur; about 25% of selected rheumatic patients experience it over 6 to 10 years, with higher risk linked to a high Wilkins score, valve calcification, or a large left atrium.
Persistent pulmonary hypertension after valve treatment requires evaluation for residual valve problems, left-heart stiffness, or lung disease; pulmonary-specific vasodilators are not routine for left-heart disease.
New symptoms, declining exercise capacity, palpitations, or an irregular rhythm should be reported before the next scheduled scan.

References (18)

1
Independent Clinical and Echocardiographic Predictors of Restenosis After Percutaneous Mitral Balloon Commissurotomy in a Large, Consecutive Cohort Followed for 24 Years.
Meneguz-Moreno RA, Ferreira-Neto AN, Gomes NL, et al.
The Journal of invasive cardiology 2023; (35(3)):E113-E121 doi:10.25270/jic/22.00328.
PMID: 36884359
2
Percutaneous Transvenous Mitral Commissurotomy for Patients with Rheumatic Heart Disease.
Li X, Zhu Y, Liang J, et al.
International heart journal 2025; (66(1)):60-65 doi:10.1536/ihj.24-330.
PMID: 39828335
3
Mitral Stenosis in the Multimodality Imaging Era: Pitfalls, Stress Echocardiography, and Integrated Therapeutic Assessment.
Pala B, Piscione M, Gaudio D, et al.
Diagnostics (Basel, Switzerland) 2026; (16(14)) doi:10.3390/diagnostics16142285.
PMID: 42510148
4
Poor outcome following percutaneous balloon mitral valvotomy in patients with atrial fibrillation.
Aslanabadi N, Ghaffari S, Khezerlouy Aghdam N, et al.
Journal of cardiovascular and thoracic research 2016; (8(3)):126-131 doi:10.15171/jcvtr.2016.26.
PMID: 27777698
5
Update on percutaneous mitral commissurotomy.
Nunes MC, Nascimento BR, Lodi-Junqueira L, et al.
Heart (British Cardiac Society) 2016; (102(7)):500-7 doi:10.1136/heartjnl-2015-308091.
PMID: 26743926
6
Analysis of Long-Term Effects of Percutaneous Balloon Mitral Valvotomy (PBMV) in 90 Patients With Rheumatic Mitral Stenosis: A Retrospective Analysis.
Xu J, Liang N, Xiao Y, et al.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026; (108(1)):124-129 doi:10.1002/ccd.70576.
PMID: 42013245
7
Mid-term (up to 12 years) clinical and echocardiographic outcomes of percutaneous transvenous mitral commissurotomy in patients with rheumatic mitral stenosis.
Dadjo Y, Moshkani Farahani M, Nowshad R, et al.
BMC cardiovascular disorders 2021; (21(1)):355 doi:10.1186/s12872-021-02175-3.
PMID: 34320949
8
Late outcome of percutaneous mitral commissurotomy: Randomized comparison of Inoue versus double-balloon technique.
Lee S, Kang DH, Kim DH, et al.
American heart journal 2017; (194()):1-8 doi:10.1016/j.ahj.2017.04.004.
PMID: 29223427
9
Updated Wilkins Score Predicting Success of Balloon Mitral Valvuloplasty in Rheumatic Mitral Stenosis.
Chichareon P, Jinpisoot N, Rasmeehiran P, et al.
JACC. Asia 2026; (6(6)):860-869 doi:10.1016/j.jacasi.2026.03.018.
PMID: 42068328
10
Effects of percutaneous balloon mitral valvuloplasty in patients with mitral stenosis and atrial fibrillation: a systematic review and meta-analysis.
Liu B, Wang Y, Liu Y, et al.
Acta cardiologica 2022; (77(10)):890-899 doi:10.1080/00015385.2021.1989837.
PMID: 34866553
11
Predictors of Very Late Events After Percutaneous Mitral Valvuloplasty in Patients With Mitral Stenosis.
Jorge E, Pan M, Baptista R, et al.
The American journal of cardiology 2016; (117(12)):1978-84.
PMID: 27131615
12
Pulmonary vascular resistance and proper timing of percutaneous balloon mitral valvotomy.
Elmaghawry LM, El-Dosouky II, Kandil NT, Sayyid-Ahmad AMS
The international journal of cardiovascular imaging 2018; (34(4)):523-529 doi:10.1007/s10554-017-1255-3.
PMID: 29086226
13
Net atrioventricular compliance can predict persistent pulmonary artery hypertension after percutaneous mitral balloon commissurotomy.
Al-Daydamony MM, Moustafaa TM
Journal of the Saudi Heart Association 2017; (29(4)):276-282 doi:10.1016/j.jsha.2017.01.001.
PMID: 28983171
14
Hemodynamics rounds: Hemodynamics of mitral valve interventions.
Lloyd JW, Rihal CS, Eleid MF
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2020; (96(3)):712-724 doi:10.1002/ccd.28755.
PMID: 32034874
15
Immediate, early and mid-term outcomes following balloon mitral valvotomy in patients having severe rheumatic mitral stenosis with significant tricuspid regurgitation.
Nair KKM, Valaparambil A, Sasidharan B, et al.
Indian journal of thoracic and cardiovascular surgery 2020; (36(5)):483-491 doi:10.1007/s12055-020-01012-0.
PMID: 33061159
16
Cardiac CT-scan for mitral valve calcification assessment before percutaneous commissurotomy: the multicentre prospective CALCIMIT study.
Alos B, Attias D, Iung B, et al.
European heart journal. Cardiovascular Imaging 2026; (27(5)):1035-1043 doi:10.1093/ehjci/jeag054.
PMID: 41729826
17
Study on the long-term curative effect of repeat percutaneous balloon mitral valvuloplasty in patients with mitral restenosis.
Zhang L, Hou J, Duan Y, et al.
Medicine 2019; (98(32)):e16790 doi:10.1097/MD.0000000000016790.
PMID: 31393407
18
Preoperative Planning of Transapical Beating Heart Mitral Valve Repair for Safe Adaptation in Clinical Practice.
Heuts S, Daemen JHT, Streukens SAF, et al.
Innovations (Philadelphia, Pa.) 2018; (13(3)):200-206 doi:10.1097/IMI.0000000000000506.
PMID: 29912141

This page is for informational purposes only and does not constitute medical advice. Your cardiologist and Heart Team should set your echocardiogram schedule and interpret your symptoms, valve function, and pulmonary pressures.

Get notified when new evidence is published on mitral valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents